-
Catecholamines A
catecholamine (/ˌkætəˈkoʊləmiːn/;
abbreviated CA) is a
monoamine neurotransmitter, an
organic compound that has a
catechol (benzene with...
- Catechol-O-methyltransferase (COMT; EC 2.1.1.6) is one of
several enzymes that
degrade catecholamines (neurotransmitters such as dopamine, epinephrine, and norepinephrine)...
-
enzyme inhibitor and is
therefore a drug
involved in
inhibiting the
catecholamine biosynthetic pathway. AMPT
inhibits tyrosine hydroxylase whose enzymatic...
- A norepinephrine–dopamine
releasing agent (NDRA) is a type of drug
which induces the
release of
norepinephrine (and epinephrine) and
dopamine in the body...
-
reduced activation of the
enhancer regulation system and
reduced brain catecholamine release with age. However, the key
endogenous actors of the enhancer...
- Monoamine-depleting
agents are a
group of
drugs which reversibly deplete one or more of the
monoamine neurotransmitters – serotonin, dopamine, and norepinephrine...
-
Monoamine precursors are
precursors of
monoamines and
monoamine neurotransmitters in the body. The
amino acids L-tryptophan and L-5-hydroxytryptophan (5-HTP;...
-
citation needed]
Numerous endogenous compounds –
including hormones,
catecholamines such as
dopamine and noradrenaline, and many
trace amines (e.g. adrenaline...
- A norepinephrine–dopamine
reuptake inhibitor (NDRI) is a drug used for the
treatment of
clinical depression,
attention deficit hyperactivity disorder (ADHD)...
- antidepressant. Tetrabe****ne, a
similar agent to reserpine,
which also
depletes catecholamine stores, and to a
lesser degree 5-HT, was
shown to
induce depression...
